Kesavelu, Dhanasekhar
Ganpathy, Sridhar
Jog, Pramod
Acharya, Bhaswati
Saxena, Vivek
Telang, Nivedita
Gaikwad, Nilesh
Funding for this research was provided by:
Sanofi
Article History
Received: 25 April 2025
Accepted: 17 June 2025
First Online: 23 July 2025
Change Date: 2 March 2026
Change Type: Clarification
Change Details: Editor’s Note: Readers are alerted that this article is currently under investigation as concerns have been raised regarding a potential undisclosed conflict of interest. Appropriate editorial action will be taken once this matter is resolved.
Declarations
:
: Sridhar Ganpathy has received speaking honoraria from Opella. Dhanasekhar Kesavelu, Pramod Jog, Bhaswati Acharya, and Vivek Saxena have nothing to disclose. Nilesh Gaikwad and Nivedita Telang are employees of Opella and may hold shares and/or stock options in the company.
: This study did not involve human participants, animal subjects, or any sensitive personal data; therefore, ethical approval was not required.